Solventum Co. (NYSE:SOLV) Receives $68.00 Consensus Target Price from Analysts

Solventum Co. (NYSE:SOLV) has been assigned a consensus rating of “Hold” from the ten research firms that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and one has assigned a buy rating to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $68.00.

Several equities analysts recently issued reports on SOLV shares. Wolfe Research started coverage on Solventum in a report on Thursday, September 26th. They issued a “peer perform” rating on the stock. Morgan Stanley raised their price target on Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a report on Monday, November 11th. Piper Sandler raised their target price on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. The Goldman Sachs Group raised their target price on Solventum from $48.00 to $54.00 and gave the stock a “sell” rating in a report on Monday, August 12th. Finally, Wells Fargo & Company reduced their target price on Solventum from $69.00 to $64.00 and set an “equal weight” rating on the stock in a report on Friday, August 9th.

Institutional Investors Weigh In On Solventum

Hedge funds have recently modified their holdings of the business. Price T Rowe Associates Inc. MD acquired a new stake in shares of Solventum during the first quarter worth about $5,889,000. Mitsubishi UFJ Trust & Banking Corp acquired a new stake in shares of Solventum during the first quarter worth about $5,747,000. CWM LLC acquired a new stake in shares of Solventum during the second quarter worth about $473,000. Great Valley Advisor Group Inc. acquired a new stake in shares of Solventum during the second quarter worth about $493,000. Finally, First Horizon Advisors Inc. acquired a new stake in shares of Solventum during the second quarter worth about $58,000.

Solventum Stock Performance

Solventum stock opened at $72.48 on Thursday. The business’s 50-day simple moving average is $70.51 and its 200 day simple moving average is $62.47. Solventum has a 12-month low of $47.16 and a 12-month high of $96.05. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.